Jasbir Seehra - Net Worth and Insider Trading
Jasbir Seehra Net Worth
The estimated net worth of Jasbir Seehra is at least $16 Million dollars as of 2024-11-13. Jasbir Seehra is the CEO of Keros Therapeutics Inc and owns about 243,856 shares of Keros Therapeutics Inc (KROS) stock worth over $16 Million. Details can be seen in Jasbir Seehra's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jasbir Seehra has not made any transactions after 2020-04-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jasbir Seehra
Jasbir Seehra Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jasbir Seehra owns 2 companies in total, including Eloxx Pharmaceuticals Inc (ELOX) , and Keros Therapeutics Inc (KROS) .
Click here to see the complete history of Jasbir Seehra’s form 4 insider trades.
Insider Ownership Summary of Jasbir Seehra
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELOX | Eloxx Pharmaceuticals Inc | 2022-06-15 | director |
| KROS | Keros Therapeutics Inc | 2020-04-13 | director & Chief Executive Officer |
Jasbir Seehra Latest Holdings Summary
Jasbir Seehra currently owns a total of 1 stock. Jasbir Seehra owns 243,856 shares of Keros Therapeutics Inc (KROS) as of April 13, 2020, with a value of $16 Million.
Latest Holdings of Jasbir Seehra
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2020-04-13 | 243,856 | 64.80 | 15,801,869 |
Holding Weightings of Jasbir Seehra
Jasbir Seehra Form 4 Trading Tracker
According to the SEC Form 4 filings, Jasbir Seehra has made a total of 1 transactions in Keros Therapeutics Inc (KROS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Keros Therapeutics Inc is the acquisition of 20,000 shares on April 13, 2020, which cost Jasbir Seehra around $320,000.
Insider Trading History of Jasbir Seehra
- 1
Jasbir Seehra Trading Performance
GuruFocus tracks the stock performance after each of Jasbir Seehra's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jasbir Seehra is 32.59%. GuruFocus also compares Jasbir Seehra's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jasbir Seehra within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jasbir Seehra's insider trading performs compared to the benchmark.
Performance of Jasbir Seehra
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.76 | | | | | |
| Relative Return to S&P 500(%) | 21.65 | | | | | |
Jasbir Seehra Ownership Network
Ownership Network List of Jasbir Seehra
Ownership Network Relation of Jasbir Seehra
Jasbir Seehra Owned Company Details
What does Eloxx Pharmaceuticals Inc do?
Who are the key executives at Eloxx Pharmaceuticals Inc?
Jasbir Seehra is the director of Eloxx Pharmaceuticals Inc. Other key executives at Eloxx Pharmaceuticals Inc include HEAD OF R&D Vijay Modur , director & PRESIDENT AND CEO Sumit Aggarwal , and Chief Financial Officer Daniel E. Geffken .
Eloxx Pharmaceuticals Inc (ELOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eloxx Pharmaceuticals Inc (ELOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eloxx Pharmaceuticals Inc (ELOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eloxx Pharmaceuticals Inc (ELOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eloxx Pharmaceuticals Inc Insider Transactions
Jasbir Seehra Mailing Address
Above is the net worth, insider trading, and ownership report for Jasbir Seehra. You might contact Jasbir Seehra via mailing address: C/o Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
